Stonehage Fleming (UK)’s MacroGenics MGNX Stock Holding History

Stonehage Fleming (UK)’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-400	Closed	-$14K	–	232
2014 Q4	$14K	Buy	+400	New	+$9.97K	0.01%	277

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Stonehage Fleming (UK)'s MGNX Position: Q1 2015 in Review

Stonehage Fleming (UK) sold out of MacroGenics (MGNX) in Q1 2015, closing a stake of 400 shares — an estimated $14K sold.

Stonehage Fleming (UK) first reported a position in MGNX in Q4 2014 and held it in 1 quarter. The position peaked at $14K in Q4 2014. 113 funds tracked by Wall St. Rank hold MGNX as of Q1 2015.

Stonehage Fleming (UK) reported no remaining MacroGenics position as of Q1 2015 after selling out during the quarter.
Stonehage Fleming (UK) sold 400 MacroGenics shares in Q1 2015, an estimated $14K.
Stonehage Fleming (UK) first reported a position in MacroGenics in Q4 2014 and held it in 1 quarter.
Stonehage Fleming (UK)'s MacroGenics position peaked at $14K in Q4 2014.
113 funds tracked by Wall St. Rank held MacroGenics as of Q1 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q1 2015, filed 11 Oct 2019.